At the virtual ASMS 2020 Reboot conference, Bruker (MA, USA) announced the first commercially available matrix-assisted laser desorption ionization-2 (MALDI-2) source, along with the innovations in Bruker’s proteomics platforms.
Scientists from the University of Birmingham (UK) are in the process of developing a new blood test that could facilitate earlier and more accurate prostate cancer detection.
Thermo Fisher Scientific (MA, USA) has expanded its Orbitrap platform with the release of new software functionalities and two new generation high-resolution mass spectrometers, which are being showcased at ASMS 2020 Reboot.
Scientists have reported a blood biomarker test that could be used to identify individuals with multiple sclerosis whose condition is likely to deteriorate in the following year.
Scientists from Prokhorov General Physics Institute of the Russian Academy of Sciences (Moscow, Russia) and the Moscow Institute of Physics and Technology (Russia) have developed a new tool to that could improve the diagnosis and monitoring of autoimmune disorders.
Thermo Fisher Scientific (MA, USA), WuXi Diagnostics (Shanghai, China) and Mayo Clinic (MN, USA) are collaborating to develop and validate a serology test for COVID-19.
The US FDA has expanded the emergency use authorization granted to Thermo Fisher Scientific’s (MA, USA) COVID-19 diagnostic test. The expansion could facilitate workflow flexibility and increase test throughput.
Researchers have developed a tool that could help to monitor the spread of infectious diseases. The newly developed blood test could provide information about whether and when an individual has been exposed to infection.
Mologic (Bedford, UK) and BioSure (Essex, UK) have entered a partnership to produce an antibody self-test for COVID-19 that does not require specialist equipment or training to carry out.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.